Clinical Trials Logo

Clinical Trial Summary

In a sample of 300 employees of the Limoges University Hospital, it is proposed to explore the intraindividual and interindividual variability of urinary concentrations of glyphosate and 320 other pesticides. The employees will fill a questionary in which will allow to explore the relationships between the concentrations, lifestyle and dietary habits.


Clinical Trial Description

The general population is exposed to pesticides through the ingestion of food and water. The presence of pesticides in human urine has been demonstrated in numerous studies. Conventionally, biological monitoring studies use an undifferentiated urine sample or the first morning urine. The reliability of measuring a single-point urinary concentration to represent the profile of pesticide exposure in individuals over time is, however, questionable. Rare studies reporting intra-individual outcomes of pesticide exposure have been conducted in specific populations, such as children and pregnant women. It is proposed to carry out a descriptive biomonitoring study of the urinary concentration of approximately 320 pesticides in a sample of the general population. Among these, the study will focus on glyphosate. The originality of our study is: - (i) Exploration of exposure to the main pesticides in a sample of 300 people by measuring urinary concentration by specific and sensitive methods of LC-MS/MS and GC-MS/MS; These 300 subjects will be hospital staff of the Limoges University Hospital. - (ii) Exploration of the intra-individual variability of exposure by repeating measurements in urine samples taken over a 24-hour period and/or several times over the course of a week; - (iii) Determination of the frequency of subjects who have potentially been exposed to doses higher than the acceptable daily intake (in particular for glyphosate) (iv) The association of these exposure values with data from a self-administered questionnaire in order to identify the determinants of this exposure - (V) Estimating the predictability/reliability of a single urine sample to represent this exposure of individuals/populations over time. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06045234
Study type Interventional
Source University Hospital, Limoges
Contact Franck SAINT-MARCOUX, Pharm D
Phone 555056143
Email franck.saint-marcoux@chu-limoges.fr
Status Recruiting
Phase N/A
Start date October 17, 2023
Completion date October 23, 2024

See also
  Status Clinical Trial Phase
Not yet recruiting NCT02775890 - Potential Lead Exposure Through Eating Self-harvested Wild Game N/A